Cancer Treatments HUB
Each guide offers clear, clinically reviewed information designed to support you at every stage of your journey.
All resources reviewed by oncology specialists | Includes biomarker and trial-matching information | Updated March 2026
Learn which lymphoma settings use CAR-T, how eligibility is assessed, what side effects to expect, and when to ask for referral.
AML CAR-T remains investigational. Learn the main targets in trials, why AML is difficult, and what questions matter before referral.
Learn where CAR-T may fit in relapsed acute lymphoblastic leukemia, which uses are approved, and which targets remain investigational.
Understand why hormone therapy is used, what “hormone-positive” can mean, common side effects, and questions to ask your care team.
Understand where TIL therapy fits in advanced melanoma, the current FDA-approved use, side effects, and when trials may matter.
Clinical trials:
Clinical trials are the foundation of medical progress. They represent a rigorous, regulated process through which new treatments—including cancer treatments, drugs, devices, and behavioral interventions—are evaluated for safety and effectiveness before becoming widely available.
For patients and families considering participation, understanding how trials work is essential. This guide provides clear, authoritative information to help you make informed decisions about cancer treatments.
Learn more about cancer:
Cancer treatments:
Most Searched Cancer
Metastatic Cancer
Breast Cancer
This site references clinical guidelines from NCCN, ASCO, ACS, ESMO, CSCO, CACA, and ChiCTR.
All resources reviewed by oncology specialists | Includes biomarker and trial-matching information | Updated March 2026
